Top News : GoPro (NASDAQ:GPRO), Amicus Therapeutics (NASDAQ:FOLD), ABIOMED(NASDAQ:ABMD), Veracyte, Inc. (NASDAQ:VCYT), Brown Shoe Co. Inc. (NYSE:BWS)

Technology Stocks News 19

GoPro, Inc. (NASDAQ:GPRO) on July 31 announced financial results for its second quarter ended June 30, 2014. Revenue in the second quarter of 2014 was $244.6 million, up 38.1% compared to the $177.1 million reported in the second quarter of 2013. Non-GAAP net income in the second quarter of 2014 was $11.8 million or $0.08 per diluted share, compared to a net loss of ($3.2) million or ($0.03) per diluted share in the second quarter of 2013 and net income of $14.3 million or $0.10 per diluted share in the first quarter of 2014. GoPro recorded a GAAP net loss in the second quarter of 2014 of $(19.8) million or $(0.24) per diluted share. GoPro, Inc. (NASDAQ:GPRO) belongs to Services sector. Its net profit margin is 3.60% and weekly performance is 19.66%. On last trading day company shares ended up $51.80. GoPro, Inc. (NASDAQ:GPRO) distance from 50-day simple moving average (SMA50) is 24.66%.

Amicus Therapeutics (NASDAQ:FOLD) VP Jayne Gershkowitz unloaded 5,000 shares of Amicus Therapeutics stock on the open market in a transaction dated Wednesday, August 27th. The shares were sold at an average price of $7.00, for a total value of $35,000.00. Following the completion of the sale, the vice president now directly owns 50,000 shares in the company, valued at approximately $350,000. Amicus Therapeutics, Inc. (NASDAQ:FOLD) shares fell -1.10% in last trading session and ended the day at $7.19. FOLD return on assets is -53.70%. Amicus Therapeutics, Inc. (NASDAQ:FOLD) quarterly performance is 192.28%.

ABIOMED news, CEO Michael R. Minogue unloaded 82,383 shares of ABIOMED stock in a transaction dated Monday, July 28th. The stock was sold at an average price of $26.30, for a total transaction of $2,166,672.90. On 29 August, ABIOMED, Inc. (NASDAQ:ABMD) shares fell -0.08% and was closed at $26.05. ABMD EPS growth in last 5 year was 17.10%. ABIOMED, Inc. (NASDAQ:ABMD) year to date (YTD) performance is -2.58%.

Veracyte, Inc. (NASDAQ:VCYT) on 13 Aug 2014 reported financial results for the second quarter ended June 30, 2014, and provided an update on business progress. For the second quarter of 2014, revenue was $8.7 million, an increase of 71%, compared to $5.1 million for the second quarter of 2013. Revenue for the six months ended June 30, 2014 was $16.2 million, compared to $9.5 million for the same period in 2013, also an increase of 71%.Veracyte, Inc. (NASDAQ:VCYT) ended the last trading day at $12.56. Company weekly volatility is calculated as 3.52%and price to cash ratio as 4.65. Veracyte, Inc. (NASDAQ:VCYT) showed a weekly performance of 0.88%.

Brown Shoe Co. said its fiscal second-quarter profit rose 18% after its wholesale business and Famous Footwear chain reported higher sales. The company’s per-share earnings outpaced market expectations, leading Brown Shoe to raise its outlook for the year. It now expects earnings between $1.50 and $1.60 a share, up from its prior forecast of $1.47 to $1.57 a share. It backed its revenue outlook. Brown Shoe Co. Inc. (NYSE:BWS) shares fell -0.83% in last trading session and ended the day on $29.84. BWS Gross Margin is 40.40% and its return on assets is 5.60%. Brown Shoe Co. Inc. (NYSE:BWS) quarterly performance is 7.49%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone